DexCom, Inc. (DXCM) vs Stryker Corporation (SYK)
DexCom, Inc. and Stryker Corporation are both Medical Devices companies. Stryker Corporation is the larger, with a market value of $103.9B against $33.0B — 3.2× the size. Stryker Corporation trades at the lower P/E: 28.0× against 33.4×. DexCom, Inc. grew revenue faster over the last twelve months: 15.5% against 8.48%. DexCom, Inc. has the higher net margin (20.1% vs 14.4%) and the higher return on invested capital (37.1% vs 9.76%). Across the 22 metrics below, DexCom, Inc. leads on 11 and Stryker Corporation on 11.
Valuation
Profitability
| Metric | DXCM | SYK | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.47% | 64.98% | 56.01% |
| Operating margin | 22.92% | 21.42% | (15.03%) |
| Net margin | 20.12% | 14.43% | (20.40%) |
| Free cash flow margin | 28.27% | 18.20% | (7.24%) |
| Return on equity | 38.49% | 16.51% | (15.32%) |
| Return on assets | 14.51% | 7.91% | (19.72%) |
| Return on invested capital | 37.13% | 9.76% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack